Capilliposide isolated from lysimachia capillipes hemsl. Induces ROS generation, cell cycle arrest, and apoptosis in human nonsmall cell lung cancer cell lines

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Fei, Zheng Hua ^a   Wu, Kan ^b   Chen, Yun Liang ^c   Wang, Bing ^b   Zhang, Shi Rong ^d   Ma, Sheng Lin ^d  

^a THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^b ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

^c WENZHOU MEDICAL UNIVERSITY   (China)

^d HANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAPILLIPOSIDE; CISPLATIN; LYSIMACHIA CAPILLIPES EXTRACT; PLANT EXTRACT; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL CYCLE ARREST; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG NON SMALL CELL CANCER; LYSIMACHIA CAPILLIPES; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 84893189438     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/497456     Document Type: Article

References (42)

1. Siegel R., Naishadham D., Jemal A., Cancer statistics, 2012. CA Cancer Journal for Clinicians 2012 62 1 10 29 2-s2.0-84855792427 10.3322/caac.20138
2. Ohe Y., Ohashi Y., Kubota K., Tamura T., Nakagawa K., Negoro S., Nishiwaki Y., Saijo N., Ariyoshi Y., Fukuoka M., Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: four-arm cooperative study in Japan. Annals of Oncology 2007 18 2 317 323 2-s2.0-33847276516 10.1093/annonc/mdl377 (Pubitemid 46323100)
3. Yang H., Landis-Piwowar K. R., Chen D., Milacic V., Dou Q. P., Natural compounds with proteasome inhibitory activity for cancer prevention and treatment. Current Protein and Peptide Science 2008 9 3 227 239 2-s2.0-47349100951 10.2174/138920308784533998 (Pubitemid 351997839)
4. Paletta-Silva R., Rocco-Machado N., Meyer-Fernandes J. R., NADPH oxidase biology and the regulation of tyrosine kinase receptor signaling and cancer drug cytotoxicity. International Journal of Molecular Sciences 14 2 3683 3704
5. Myatt S. S., Brosens J. J., Lam E. W.-F., Sense and sensitivity: FOXO and ROS in cancer development and treatment. Antioxidants and Redox Signaling 2011 14 4 675 687 2-s2.0-79251585292 10.1089/ars.2010.3383
6. Benhar M., Engelberg D., Levitzki A., ROS, stress-activated kinases and stress signaling in cancer. EMBO Reports 2002 3 5 420 425 2-s2.0-0035984912 10.1093/embo-reports/kvf094 (Pubitemid 34567428)
7. Shi X., Zhao Y., Jiao Y., Shi T., Yang X., ROS-dependent mitochondria molecular mechanisms underlying antitumor activity of Pleurotus abalonus acidic polysaccharides in human breast cancer MCF-7 cells. PLoS ONE 8 5 e64266
8. Liang B., Zhang L., Tian J., Xu L., Yang S., Isolation and characterization of two new saponins from Lysimachia capillipes. Carbohydrate Research 2006 341 14 2444 2448 2-s2.0-33747785606 10.1016/j.carres.2006.06.020 (Pubitemid 44279600)
9. Tian J.-K., Xu L.-Z., Zou Z.-M., Yang S.-L., Two new triterpene saponins from Lysimachia capillipes. Journal of Asian Natural Products Research 2006 8 5 439 444 2-s2.0-33746837657 10.1080/10286020500173259 (Pubitemid 44180287)
10. Ying H.-M., Qi Z.-J., Guo D.-W., Yu T.-L., Zhang L., Tian J.-K., Quantitative determination of capilliposide B and capilliposide C in Lysimachia capillipes by HPLC-ELSD assay. Chinese Pharmaceutical Journal 2011 46 9 704 706 2-s2.0-79958774884
11. Xu Y., Rong Y. M., Jk T., Experimental studies on anti-tumor effects of capilliposide. Chinese Pharmacological Bulletin 28 4 545 549
12. Tian J.-K., Xu L.-Z., Zou Z.-M., Yang S.-L., Three novel triterpenoid saponins from Lysimachia capillipes and their cytotoxic activities. Chemical and Pharmaceutical Bulletin 2006 54 4 567 569 2-s2.0-33645536164 10.1248/cpb.54.567
13. Khan M., Yu B., Rasul A., Al Shawi A., Yi F., Yang H., Ma T., Jaceosidin induces apoptosis in U87 glioblastoma cells through G2/M phase arrest. Evidence-Based Complementary and Alternative Medicine 2012 2012 12 2-s2.0-84855599048 10.1155/2012/703034 703034
14. Looi C. Y., Imanishi M., Takaki S., Sato M., Chiba N., Sasahara Y., Futaki S., Tsuchiya S., Kumaki S., Octa-arginine mediated delivery of wild-type Lnk protein inhibits TPO-induced M-MOK Megakaryoblastic leukemic cell growth by promoting apoptosis. PLoS ONE 2011 6 8 2-s2.0-80051531340 10.1371/journal.pone. 0023640 e23640
15. Freedman V. H., Shin S., Cellular tumorigenicity in nude mice: correlation with cell growth in semi solid medium. Cell 1974 3 4 355 359 2-s2.0-0016318441
16. Gao J., Morgan W. A., Sanchez-Medina A., Corcoran O., The ethanol extract of Scutellaria baicalensis and the active compounds induce cell cycle arrest and apoptosis including upregulation of p53 and Bax in human lung cancer cells. Toxicology and Applied Pharmacology 2011 254 3 221 228 2-s2.0-80053953558 10.1016/j.taap.2011.03.016
17. Lee J. H., Yeon J. H., Kim H., The natural anticancer agent plumbagin induces potent cytotoxicity in MCF-7 human breast cancer cells by inhibiting a PI-5 kinase for ROS generation. PLoS ONE 7 9 e45023
18. Reuss D. E., Mucha J., Hagenlocher C., Sensitivity of malignant peripheral nerve sheath tumor cells to TRAIL is augmented by loss of NF1 through modulation of MYC/MAD and is potentiated by curcumin through induction of ROS. PLoS ONE 8 2 e57152
19. Chiu H.-W., Ho Y.-S., Wang Y.-J., Arsenic trioxide induces autophagy and apoptosis in human glioma cells in vitro and in vivo through downregulation of survivin. Journal of Molecular Medicine 2011 89 9 927 941 2-s2.0-80052467543 10.1007/s00109-011-0763-1
20. Gu H., Rao S., Zhao J., Wang J., Mu R., Rong J., Tao L., Qi Q., You Q., Guo Q., Gambogic acid reduced bcl-2 expression via p53 in human breast MCF-7 cancer cells. Journal of Cancer Research and Clinical Oncology 2009 135 12 1777 1782 2-s2.0-70349773507 10.1007/s00432-009-0624-2
21. Xu W. S., Dang Y. Y., Chen X. P., Lu J. J., Wang Y. T., Furanodiene presents synergistic anti-proliferative activity with paclitaxel via altering cell cycle and integrin signaling in 95-D lung cancer cells. Phytotherapy Research 2013 10.1002/ptr.4984
22. Ma L., Wen Z.-S., Liu Z., Hu Z., Ma J., Chen X.-Q., Liu Y.-Q., Pu J.-X., Xiao W.-L., Sun H.-D., Zhou G.-B., Overexpression and small molecule-triggered downregulation of CIP2A in lung cancer. PLoS ONE 2011 6 5 2-s2.0-79957864490 10.1371/journal.pone.0020159 e20159
23. Low P. S., Henne W. A., Doorneweerd D. D., Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Accounts of Chemical Research 2008 41 1 120 129 2-s2.0-38949215454 10.1021/ar7000815
24. Wyllie A. H., Kerr J. F. R., Currie A. R., Cell death: the significance of apoptosis. International Review of Cytology 1980 68 251 306 2-s2.0-0019225636 (Pubitemid 11219226)
25. Cooper W. A., Kohonen-Corish M. R. J., Zhuang L., McCaughan B., Kennedy C., Screaton G., Sutherland R. L., Lee C.-S., Role and prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand death receptor DR5 in nonsmall-cell lung cancer and precursor lesions. Cancer 2008 113 1 135 142 2-s2.0-47149091701 10.1002/cncr.23528 (Pubitemid 351976394)
26. Willingham M. C., Cytochemical methods for the detection of apoptosis. Journal of Histochemistry and Cytochemistry 1999 47 9 1101 1109 2-s2.0-0032870081 (Pubitemid 29418314)
27. Aghaei M., Panjehpour M., Karami-Tehrani F., Salami S., Molecular mechanisms of A3 adenosine receptor-induced G1 cell cycle arrest and apoptosis in androgen-dependent and independent prostate cancer cell lines: involvement of intrinsic pathway. Journal of Cancer Research and Clinical Oncology 2011 137 10 1511 1523 2-s2.0-80054727886 10.1007/s00432-011-1031-z
28. 2-induced autophagic cell death by propofol in H9c2 cardiomyocytes. Cell Biology and Toxicology 2012 28 1 19 29 2-s2.0-84858708667 10.1007/s10565-011-9202-x
29. Fulda S., Debatin K.-M., Targeting apoptosis pathways in cancer therapy. Current Cancer Drug Targets 2004 4 7 569 576 2-s2.0-8844263797 10.2174/1568009043332763 (Pubitemid 39536377)
30. Kim H. J., Yang K. M., Park Y. S., The novel resveratrol analogue HS-1793 induces apoptosis via the mitochondrial pathway in murine breast cancer cells. International Journal of Oncology 41 5 1628 1634
31. Leber B., Geng F., Kale J., Andrews D. W., Drugs targeting Bcl-2 family members as an emerging strategy in cancer. Expert Reviews in Molecular Medicine 2010 12, article e28 2-s2.0-79952112980
32. Kaparou M., Choumerianou D., Perdikogianni C., Enhanced levels of the apoptotic BAX/BCL-2 ratio in children with acute lymphoblastic leukemia and high-risk features. Genetics and Molecular Biology 36 1 7 11
33. Inoue A., Takitani K., Koh M., Kawakami C., Kuno T., Tamai H., Induction of apoptosis by -Tocotrienol in human cancer cell lines and leukemic blasts from patients: dependency on bid, cytochrome c, and caspase pathway. Nutrition and Cancer 2011 63 5 763 770 2-s2.0-79960617315 10.1080/01635581.2011.563030
34. Lin H.-I., Lee Y.-J., Chen B.-F., Tsai M.-C., Lu J.-L., Chou C.-J., Jow G.-M., Involvement of Bcl-2 family, cytochrome c and caspase 3 in induction of apoptosis by beauvericin in human non-small cell lung cancer cells. Cancer Letters 2005 230 2 248 259 2-s2.0-27744579438 10.1016/j.canlet.2004.12.044 (Pubitemid 41612468)
35. Drexler H. G., Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells. Leukemia 1998 12 6 845 859 2-s2.0-0031860559 (Pubitemid 28287205)
36. Park M. A., Hwang K. A., Lee H. R., Benzophenone-1 stimulated the growth of BG-1 ovarian cancer cells by cell cycle regulation via an estrogen receptor alpha-mediated signaling pathway in cellular and xenograft mouse models. Toxicology 305 41 48
37. Lane D. P., p53, guardian of the genome. Nature 1992 358 6381 15 16 2-s2.0-0027109075 10.1038/358015a0
38. Wang Q., Su L., Liu N., Zhang L., Xu W., Fang H., Cyclin dependent kinase 1 inhibitors: a review of recent progress. Current Medicinal Chemistry 2011 18 13 2025 2043 2-s2.0-79957937959 10.2174/092986711795590110
39. Martin D. A., Elkon K. B., Mechanisms of apoptosis. Rheumatic Disease Clinics of North America 30 3 441 454
40. Dewaele M., Maes H., Agostinis P., ROS-mediated mechanisms of autophagy stimulation and their relevance in cancer therapy. Autophagy 2010 6 7 838 854 2-s2.0-77957681100 10.4161/auto.6.7.12113
41. You B. R., Park W. H., Zebularine-induced apoptosis in Calu-6 lung cancer cells is influenced by ROS and GSH level changes. Tumour Biology 34 2 1145 1153
42. Strickertsson J. A., Desler C., Martin-Bertelsen T., Enterococcus faecalis infection causes inflammation, intracellular oxphos-independent ROS production, and DNA damage in human gastric cancer cells. PLoS ONE 8 4 e63147